Operating Expenses

R&D

Church & Dwight R&D decreased by 12.7% to $31.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.7%, from $32.80M to $31.60M.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.

Detailed definition

Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...

Peer comparison

Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.

Metric ID: research_and_development

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$25.40M$27.70M$24.50M$27.20M$29.20M$26.70M$30.20M$30.30M$30.10M$33.00M$36.00M$32.80M$35.80M$36.20M$31.60M
QoQ Change+9.1%-11.6%+11.0%+7.4%-8.6%+13.1%+0.3%-0.7%+9.6%+9.1%-8.9%+9.1%+1.1%-12.7%
YoY Change+7.1%+5.4%+9.0%+11.0%+3.8%+12.7%+9.3%+18.8%+9.0%+8.5%+0.6%-3.7%
Range$24.50M$36.20M
CAGR+6.4%
Avg YoY Growth+7.6%
Median YoY Growth+8.7%

Business Segments

View all
SegmentQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Consumer Domestic$29.20M$31.80M$32.30M$35.80M$27.80M
Consumer International$3.00M$3.20M$3.20M$4.10M$3.00M
Specialty Products Division$600.00K$800.00K$700.00K$900.00K$800.00K
Consolidating Reclassification$0.00$0.00$0.00$0.00$0.00
Total$32.80M$35.80M$36.20M$31.60M

Frequently Asked Questions

What is Church & Dwight's r&d?
Church & Dwight (CHD) reported r&d of $31.60M in Q1 2026.
How has Church & Dwight's r&d changed year-over-year?
Church & Dwight's r&d decreased by 3.7% year-over-year, from $32.80M to $31.60M.
What does r&d mean?
The money spent on creating new products or improving existing ones to drive future growth.